Showing results (1781-1790 of 1,873) with videos related to
Sort By:
Pageof 188
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 TherapyJarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.Nature Communications|March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMatthew J Niederst, Lecia V Sequist, John T Poirier, et al.JAMA|June 1, 2026
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical TrialJamie E Chaft, Zhuoxin Sun, Charles M Rudin, et al.Journal of the American Society of Nephrology : JASN|April 3, 2021
Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural DeafnessKarl P Schlingmann, Aparna Renigunta, Ewout J Hoorn, et al.Biorxiv : the Preprint Server for Biology|May 3, 2023
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.Nature Medicine|October 3, 2017
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysisRodrigo Romero, Volkan I Sayin, Shawn M Davidson, et al.Cancer Discovery|July 16, 2021
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent PembrolizumabPrasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, et al.JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.Stroke|January 31, 2023
Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort StudyTolga D Dittrich, Peter B Sporns, Lilian F Kriemler, et al.Cancer Cell|July 19, 2024
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.Pageof 188